Trial Information
Inclusion Criteria:
- CLL patients and controls who have been vaccinated with PCV in our previous study
Exclusion Criteria:
- Vaccinated with PPV-vaccine within the last 5 years, immunoglobulin substitution,
corticosteroid treatment (equivalent of 20mg prednisolone per day)
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Outcome Measure:
Antibody response
Outcome Time Frame:
1-3 months
Safety Issue:
Yes
Authority:
Finland: Finnish Medicines Agency
Study ID:
R09082M
NCT ID:
NCT00919321
Start Date:
June 2009
Completion Date:
December 2012
Related Keywords:
- Chronic Lymphocytic Leukemia (CLL)
- CLL
- PPV
- PCV
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid